Horizon Pharma Announces Preliminary Fourth Quarter and Full Year 2012 Revenues, Full U.S. Commercial Launch of RAYOS(R) (Prednisone) Delayed-Release Tablets and Approval of LODOTRA(R) in South Korea

[at noodls] – DEERFIELD, IL — (Marketwire) — 02/11/13 — Horizon Pharma, Inc. (NASDAQ: HZNP) today announced preliminary (unaudited) revenues for the fourth quarter and fiscal year ended December 31, 2012. Full year … more

View todays social media effects on HZNP

View the latest stocks trending across Twitter. Click to view dashboard

See who Horizon is hiring next, click here to view